The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "June 2016” and “June 2016.”
According to the above filters, the following are recent buys and sells from company insiders in the past week.
On June 22, Coliseum Capital Management, L, director and 10% owner of BioScrip Inc. (BIOS), bought 4,200,000 shares for $2 per share. Since then, the price of the stock has risen by 38.0% to $2.76.
During the last 12 months, the price of the stock has dropped by 23% and is now trading with a P/S ratio of 0.19. The price is 29.26% below its 52-week high and 133.61% above its 52-week low.
The company has an insider ownership of 2.81%, and institutional ownership of 83.54%. It provides home infusion and other home health care services to patients, physicians, hospitals, health care payors and pharmaceutical manufacturers to provide clinical management solutions and delivers cost-effective access to medications.
On June 21, Broadwood Partners LP, director and 10% owner of BioTime Inc. (BTX), bought 2,732,636 shares for $2.39 per share. Since then, the price of the stock has risen by 2.5% to $2.45.
The company has an insider ownership of 2.81%, and institutional ownership of 83.54%. It is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology.
During the last 12 months, the price of the stock has dropped by 33% and is now trading with a P/B ratio of 21.45. The price is 45.68% below its 52-week high and 21.29% above its 52-week low.
On June 21, Grupo Ferrer Internacional, S, 10% owner of Alexza Pharmaceuticals Inc. (ALXA), bought 19,456,714 shares for 90 cents per share. Since then, the price of the stock has risen by 4.4% to 94 cents per share.
The company has an insider ownership of 2.17%, and institutional ownership of 35.32%. It is a pharmaceutical company engaged in the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product includes ADASUVE.
During the last 12 months, the price of the stock has dropped by 24% and is now trading with a P/S ratio of 3.70. The price is 37.50% below its 52-week high and 354.55% above its 52-week low.
On June 19, Roelof Botha, director and 10% owner of Natera Inc. (NTRA), bought 837,521 shares for $11.94 per share. Since then, the price of the stock has risen by 14.1% to $13.62.
The company has an insider ownership of 7.00%, and institutional ownership of 49.30%. It is a diagnostics company with proprietary molecular and bioinformatics technology that it is deploying to change the management of genetic disease.
During the last 12 months, the price of the stock has dropped by 47%; the price is 50.82% below its 52-week high and 83.74% above its 52-week low.
Most important sales of the week
On June 23, Spirit Bear Ltd., 10% owner of Cool Technologies Inc. (WARM), sold 230,000 shares for 9 cents per share. Since then, the price of the stock has dropped by 11.1% to 8 cents.
The company has an institutional ownership of 5.72%, and it is engaged in the development and commercialization of a single patent, a composite heat pipe. The company's technologies are divided into three categories: heat dispersion technology, mobile electric power and electric load assist.
During the last 12 months, the price of the stock has dropped by 80%; the price is 86.44% below its 52-week high and 30.90% above its 52-week low.
On June 21, Chief Technology Officer John Allspaw, director of Etsy Inc. (ETSY), sold 206,312 shares for $10 per share. Since then, the price of the stock has dropped by 0.7% to $9.93.
The company has an institutional ownership of 45.44% and insider ownership of 1.70%. It operates a marketplace where people around the world connect, both online and offline, to make, sell and buy goods
During the last 12 months, the price of the stock has dropped by 33% and is now trading with a P/B ratio of 3.40. The price is 57.64% below its 52-week high and 64.40% above its 52-week low.
On June 20 Children's Hospital of Philadelphia,10% owner of Spark Therapeutics Inc. (ONCE), sold 1,000,000 shares for $42.30 per share. Since then, the price of the stock has risen by 12.6% to $47.64.
The company has an institutional ownership of 72.48% and insider ownership of 2.09%. It is engaged in developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.
During the last 12 months, the price of the stock has dropped and is now trading with a P/B ratio of 4.51. The price is 34.98% below its 52-week high and 120.05% above its 52-week low.
On June 20, J. Alexander Douglas Jr., executive vice president of Coca-Cola Co. (KO), sold 572,748 shares for $45.25 per share. Since then, the price of the stock has dropped by 0.4% to $45.08.
The company has an institutional ownership of 66.09% and insider ownership of 0.32%. It manufactures, distributes and markets nonalcoholic beverage concentrates and syrups.
During the last 12 months, the price of the stock has risen by 12% and is now trading with a P/B ratio of 7.82. The price is 4.82% below its 52-week high and 22.70% above its 52-week low.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Start a free seven-day trial of Premium Membership to GuruFocus.
